Nuvectis Pharma
NVCT
NVCT
36 hedge funds and large institutions have $12.8M invested in Nuvectis Pharma in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
+3
Holders Change %
+9.09%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
16
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
$382K |
| 2 |
Millennium Management
New York
|
$284K |
| 3 |
BlackRock
New York
|
$3.24M |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
$228K |
| 5 |
Renaissance Technologies
New York
|
$432K |
